Despite accounting for a considerable number of deaths among HFpEF patients, sudden cardiac death (SCD) remains poorly ...

Adona Medical, a Shifamed portfolio company that is developing one of the world's first combined therapeutic/diagnostic ...

The funds will allow Corvia to accumulate the final clinical data required to support a submission for the system with the ...

Corvia Medical announced today that it closed a $55 million funding round to support the advancement of its Corvia atrial ...

The DASH (Dietary Approaches to Stop Hypertension) diet effectively treated high blood pressure among type 2 diabetics, ...

The Mesoblast Ltd (ASX: MSB) share price reached an intraday peak of $1.94 today, which is a 10-week high. Is an upward trend ...

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...

Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...

“People who reported difficulty lifting five kilograms had a significantly higher risk of experiencing a lower quality of ...

The development of aortic valve sclerosis may signal disease progression in patients with chronic heart failure.